The Role of Mesenchymal Stem Cells in Modulating Adaptive Immune Responses in Multiple Sclerosis
Cells · 16.09.2024 · 13 (18) · 1556
DOI: 10.3390/cells13181556 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 16.09.2024. Verfasst von Sepehr Dadfar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Semnan University of Medical Sciences, Semnan 35147-99442, Iran. Hauptthemen laut MEDLINE: Multiple Sclerosis, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation, Adaptive Immunity. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system, leading to significant disability through neurodegeneration. Despite advances in the understanding of MS pathophysiology, effective treatments remain limited. Mesenchymal stem cells (MSCs) have gained attention as a potential therapeutic option due to their immunomodulatory and regenerative properties. This review examines MS pathogenesis, emphasizing the role of immune cells, particularly T cells, in disease progression, and explores MSCs’ therapeutic potential. Although preclinical studies in animal models show MSC efficacy, challenges such as donor variability, culture conditions, migratory capacity, and immunological compatibility hinder widespread clinical adoption. Strategies like genetic modification, optimized delivery methods, and advanced manufacturing are critical to overcoming these obstacles. Further research is needed to validate MSCs’ clinical application in MS therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Student Research Committee, Semnan University of Medical Sciences, Semnan 35147-99442, Iran.
- Department of Immunology, School of Medicine, Semnan University of Medical Sciences, Semnan 35147-99442, Iran.
- Cancer Research Center, Semnan University of Medical Sciences, Semnan 35147-99442, Iran.
- Department of Bacteriology and Virology, Semnan University of Medical Sciences, Semnan 35147-99442, Iran.
- Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, 5020 Bergen, Norway.
ORCID-Profile: Sepehr Dadfar, Alireza Pazoki, Mohammad Hossein Nemati, Dariush Haghmorad, Valentyn Oksenych
Zitieren
APA
Dadfar, S., Yazdanpanah, E., Pazoki, A., Nemati, M. H., Eslami, M., Haghmorad, D., & Oksenych, V. (2024). The Role of Mesenchymal Stem Cells in Modulating Adaptive Immune Responses in Multiple Sclerosis. Cells, 13(18), 1556. https://doi.org/10.3390/cells13181556
Vancouver
Dadfar S, Yazdanpanah E, Pazoki A, Nemati MH, Eslami M, Haghmorad D, et al. The Role of Mesenchymal Stem Cells in Modulating Adaptive Immune Responses in Multiple Sclerosis. Cells. 2024;13(18):1556. doi:10.3390/cells13181556
BibTeX
@article{Dadfar2024,
author = {Dadfar, Sepehr and Yazdanpanah, Esmaeil and Pazoki, Alireza and Nemati, Mohammad Hossein and Eslami, Majid and Haghmorad, Dariush and Oksenych, Valentyn},
title = {The Role of Mesenchymal Stem Cells in Modulating Adaptive Immune Responses in Multiple Sclerosis},
journal = {Cells},
year = {2024},
volume = {13},
number = {18},
pages = {1556},
doi = {10.3390/cells13181556}
}
EUVIMED